Home
NewsNewsTest tube baby treatment will begin at the Castle Street Hospital, expanding IVF access in public healthcare system of Sri Lanka for couples facing infertility and marking a new chapter in the reproductive health services of the nation.
Sri Lanka introduces test tube baby treatment at the Castle Street Hospital for Women in Colombo, marking the first time IVF services will be offered through a government hospital.
The official said this facility would mean that in vitro fertilization, or IVF, would be available under the public healthcare sector. Till date, fertility treatments have been limited to private hospitals only. He added that this will help couples who cannot afford expensive treatments at private hospitals.
Director of the Castle Street Hospital for Women, Dr. Ajith Kumara Danthanarayana said the facility is nearing readiness.
“The new facility is expected to be operational within the next three months. This is an important step in providing advanced reproductive health services through the public healthcare system,”
“Our aim is to ensure that couples who cannot afford expensive private treatment are given a fair opportunity to fulfill their dream of parenthood,” he said.
At present, test tube baby treatment in Sri Lanka is available only at a small number of private hospitals, where a single IVF cycle typically costs between Rs. 2 million and Rs. 3 million.
IVF is a procedure in which an egg is fertilized with sperm outside the body in a lab and then put into the uterus. IVF treatment is being performed to overcome infertility caused by blocked fallopian tubes, low sperm count, an imbalance of hormones, or even unknown causes.
Doctors said that initiating an IVF facility in a government hospital will be a welcome step, as increasing numbers of couples are suffering from infertility problems and facing mental trauma for not being able to access treatment.
A federal judge has approved a class-action settlement requiring Aetna to extend equal Fertility Coverage for Same-Sex Couples, aligning it with existing benefits for heterosexual partners.
OTO Launches Fertility Diagnostic Wearable featuring Cira, new patented biometric and AI-powered wrist-worn biosensor technology designed to decode reproductive preparedness with precision and personalized insights.
President Trump’s IVF initiative announces most-favored-nation pricing with EMD Serono to slash fertility drug costs and launches TrumpRx.gov access, alongside new guidance enabling employer fertility benefits. FDA will expedite Pergoveris review, aiming to improve affordability, access, and outcomes for Americans seeking IVF treatment.
Infertility Treatment Drugs from Merck have enabled the births of 6 million babies globally, with 50% of conceived individuals tied to its therapies.
Aksigen IVF has launched an innovative Immersive IVF Knowledge Centre in Mumbai, dedicated to advancing fertility education by demystifying complex IVF science and empowering patients to make informed, confident decisions about their family planning journey.
Hana Health from DSS Imagetech and Overture Life collaborate to bring irst Automated Egg-Freezing Technology in India, giving couples access to a technology that reduces variability at the critical egg-freezing stage for successful pregnancy and healthy child birth.
According to a landmark large-scale IVF trial, using natural ovulation for frozen embryo transfers achieves matching birth rates to standard hormone cycles, offering a safer alternative for women.
